BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26923331)

  • 1. Non-migratory tumorigenic intrinsic cancer stem cells ensure breast cancer metastasis by generation of CXCR4(+) migrating cancer stem cells.
    Mukherjee S; Manna A; Bhattacharjee P; Mazumdar M; Saha S; Chakraborty S; Guha D; Adhikary A; Jana D; Gorain M; Mukherjee SA; Kundu GC; Sarkar DK; Das T
    Oncogene; 2016 Sep; 35(37):4937-48. PubMed ID: 26923331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of CXCL12-CXCR4 signalling induces conversion of immortalised embryonic kidney cells into cancer stem-like cells.
    Oh SI; Jeong H; Park HS; Choi KA; Hwang I; Lee J; Cho J; Hong S
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):1303-1313. PubMed ID: 33150801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways.
    Sobolik T; Su YJ; Wells S; Ayers GD; Cook RS; Richmond A
    Mol Biol Cell; 2014 Mar; 25(5):566-82. PubMed ID: 24403602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.
    Bertolini G; D'Amico L; Moro M; Landoni E; Perego P; Miceli R; Gatti L; Andriani F; Wong D; Caserini R; Tortoreto M; Milione M; Ferracini R; Mariani L; Pastorino U; Roato I; Sozzi G; Roz L
    Cancer Res; 2015 Sep; 75(17):3636-49. PubMed ID: 26141860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of metastatic cancer stem cells from the NK/LAK-resistant floating, but not adherent, subset of the UP-LN1 carcinoma cell line by IFN-γ.
    Chen HC; Chou AS; Liu YC; Hsieh CH; Kang CC; Pang ST; Yeh CT; Liu HP; Liao SK
    Lab Invest; 2011 Oct; 91(10):1502-13. PubMed ID: 21691263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
    Han S; Guo J; Liu Y; Zhang Z; He Q; Li P; Zhang M; Sun H; Li R; Li Y; Zeng W; Liu J; Lian L; Gao Y; Shen L
    Oncotarget; 2015 Dec; 6(42):44452-65. PubMed ID: 26540347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.
    Rodríguez M; Silva J; Herrera A; Herrera M; Peña C; Martín P; Gil-Calderón B; Larriba MJ; Coronado MJ; Soldevilla B; Turrión VS; Provencio M; Sánchez A; Bonilla F; García-Barberán V
    Oncotarget; 2015 Dec; 6(38):40575-87. PubMed ID: 26528758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo.
    Lapteva N; Yang AG; Sanders DE; Strube RW; Chen SY
    Cancer Gene Ther; 2005 Jan; 12(1):84-9. PubMed ID: 15472715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer stem cell activity and chemotaxis.
    DeCastro AJ; Cherukuri P; Balboni A; DiRenzo J
    Mol Cancer Ther; 2015 Jan; 14(1):225-35. PubMed ID: 25376609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell autocrine CXCL12/CXCR4 stimulates invasion and metastasis of esophageal cancer.
    Wang X; Cao Y; Zhang S; Chen Z; Fan L; Shen X; Zhou S; Chen D
    Oncotarget; 2017 May; 8(22):36149-36160. PubMed ID: 28193907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pomolic Acid Inhibits Invasion of Breast Cancer Cells Through the Suppression of CXC Chemokine Receptor Type 4 Expression.
    Kim B; Kim JH; Park B
    J Cell Biochem; 2016 Jun; 117(6):1296-307. PubMed ID: 26495998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity.
    Ablett MP; O'Brien CS; Sims AH; Farnie G; Clarke RB
    Oncotarget; 2014 Feb; 5(3):599-612. PubMed ID: 24583601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma.
    Kato M; Kitayama J; Kazama S; Nagawa H
    Breast Cancer Res; 2003; 5(5):R144-50. PubMed ID: 12927045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
    Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
    Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic Knockout of CXCR4 Expression by a Novel Intrakine Mutant hSDF-1α/54/KDEL Inhibits Breast Cancer Metastasis.
    Chen HY; Clayman ES; Ma WF
    J Interferon Cytokine Res; 2015 Oct; 35(10):771-8. PubMed ID: 25978539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
    Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
    J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
    Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
    Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer.
    Liu X; Xiao Q; Bai X; Yu Z; Sun M; Zhao H; Mi X; Wang E; Yao W; Jin F; Zhao L; Ren J; Wei M
    Oncol Rep; 2014 Dec; 32(6):2760-8. PubMed ID: 25310198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H; Mansel RE; Jiang WG
    Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.